TOKYO, Dec. 11, 2024 /PRNewswire/ — Nippon Express (China) Co., Ltd. (hereafter “NX China”), a group company of NIPPON EXPRESS HOLDINGS, INC., took part in the five-day 2nd China International Supply Chain Expo (CISCE) held at the China International Exhibition Center in Beijing, China, from Tuesday, November 26, to Saturday, November 30.
NX Logo: https://kyodonewsprwire.jp/img/202412051171-O3-yOR8YJ29
Exhibit booth:
https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202412051171/_prw_PI2fl_tL9D8QxM.jpg
Business discussion:
https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202412051171/_prw_PI1fl_1Aj3D1vd.jpg
One of China’s largest exhibitions, CISCE is hosted by the China Council for the Promotion of International Trade (CCPIT) under the theme “Connecting the World for a Shared Future.” This year’s event attracted 160,000 visitors, approximately 1.3 times the number at last year’s inaugural expo, with exhibits of the latest supply chain technologies, products, and services in the fields of smart cars, green agriculture, clean energy, digital technology, and healthcare presented by nearly 700 companies and organizations from 69 countries/regions.
The NX China booth introduced the NX Group’s network, which includes new companies such as cargo-partner GmbH of Austria as well as air, ocean, and ground transport mode-specific services and environmentally friendly services that offer end-to-end support for customers’ supply chains.
The NX Group will continue meeting the logistics challenges of its customers and supporting their business expansion with its global network and accumulated expertise in advanced logistics.
About the NX Group:
https://kyodonewsprwire.jp/attach/202412051171-O1-Dnf658d1.pdf
NX Group official website: https://www.nipponexpress.com/
NX Group’s official LinkedIn account: https://www.linkedin.com/company/nippon-express-group/
ข่าวที่เกี่ยวข้อง
- METiS TechBio, the World’s First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, “The SpaceX of Pharmaceuticals” Ushers in a New Era of Biopharmaceuticals
- Join the 2026 SDG Asia Expo to “Shape Our Future” for Sustainability in Asia
- Hi & Fi Asia-China 2026 Enters One-Month Countdown, Connecting Asia’s Food & Health Industry in Shanghai
- MEDIPOST’s CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
